Simple Summary In four neuroendocrine tumor (NET) centers, we structurally assessed the
involvement of the central nervous system with a focus on leptomeningeal carcinomatosis …

Leptomeningeal carcinomatosis carries a poor prognosis in breast cancer. Treatment
modalities are geared towards tumour molecular characteristics, as well as symptoms and …

We present a 77-year-old previously well patient with facial asymmetry and progressive
weakness of the lower extremities. An initial MRI revealed slight contrast enhancement of …

BACKGROUND Leptomeningeal carcinomatosis is a rare feature of metastasis that is
characterized by thickening and increased contrast enhancement throughout the meninges …

Discussion Clinical manifestations of LC reflect multifocal involvement of the central nervous
system (CNS). Neurologic dysfunction results from direct invasion of malignant cells and …

Leptomeningeal carcinomatosis (LC) is a rare complication of primary malignancy that
spreads to leptomeninges and cerebrospinal fluid (CSF). Due to its rarity, it is often …

INTRODUCTION: Leptomeningeal carcinomatosis (LC) is a devastating complication
occurring in 5% of all patients with cancer. To date there are no well-established prognostic …

Leptomeningeal carcinomatosis (LC) is a rare but serious complication of cancer in which
cancer cells spread to the leptomeninges, the membranes that surround the brain and spinal …

Leptomeningeal carcinomatosis (LC), characterized by the spread of malignant cells to the
leptomeninges, has a poor prognosis. 1, 2 In the presence of neurologic symptoms …

BACKGROUND: Leptomeningeal carcinomatosis (LC) represents a devastating
complication of systemic cancer, and patients with LC have a dismal prognosis and …